Home › Peripheral Arterial Disease › New Jersey
Pag-aaral pangklinika para sa Peripheral Arterial Disease sa New Jersey
7 pag-aaral para sa Peripheral Arterial Disease ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Mga Lungsod sa New Jersey
Opisyal na teksto ng pag-aaral (English)
The THOR IDE Study
- Deborah Heart and Lung Center, Browns Mills
- Heart and Vascular Institute of Central Jersey, New Brunswick
- Atlantic Medical Imaging of New jersey, Vineland
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05916950Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Advanced Heart and Vascular Institute of Hunterdon, Flemington
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07318610EVERO Drug-coated Balloon (DCB) Randomized Trial
- Cooper University Hospital, Camden
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07144150Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Rutgers University, Newark
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04774159Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Advanced Heart and Vascular Institute, Flemington
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06321575Serranator POINT FORCE Registry
- Atlantic Medical Imaging, Brick
- Virtua Health, Marlton
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT06687590Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.